Results 121 to 130 of about 2,854 (152)
[Anticholesteremic agents and cholelithiasis].
Nihon rinsho. Japanese journal of clinical medicine, 1978 G, Kajiyama +3 more
openaire +2 more sources
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases [PDF]
The Cochrane Library, 2017 BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and disability worldwide, yet ASCVD risk factor control and secondary prevention rates remain low.
Angharad N De Cates +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
[Anticholesteremic agents in children].
Therapie, 2003The treatment of hypercholesterolaemia in children is often discussed as part of the primary prevention strategy for premature coronary disease in adults. Cholesterol-lowering drugs are appropriate in children with hereditary autosomal dominant diseases such as familial hypercholesterolaemia, familial Apo B100 deficiency, or combined familial ...
openaire +1 more source
Risk scoring for the primary prevention of cardiovascular disease
The Cochrane Library, 2021Kunal N Karmali +2 more
exaly
Anticholesteremic agents, statins, modulate monocyte activation in cultured human THP-1 cells
, 2013 Fumihide Takano +5 more
openalex
[Further clinical research on a new anticholesteremic agent (4-diphenylyl ethyl-acetic acid)].
, 1958 G Annoni
openalex